Enhanced Recovery After Surgery (ERAS) in Surgical Oncology

Curr Oncol Rep. 2022 Sep;24(9):1177-1187. doi: 10.1007/s11912-022-01282-4. Epub 2022 Apr 11.


Purpose of the review: The objective of this review is to address the rationale behind the application of the Enhanced Recovery After Surgery (ERAS) protocols that could improve oncologic outcomes in adult patients undergoing major surgery.

Recent findings: The implementation of ERAS protocols has been associated with fewer postoperative complications as well as decreased return to intended oncologic treatment (RIOT). However, few studies have analyzed the influence of the application of ERAS protocols and long-term oncologic outcomes, although some of its individual elements have been associated with improvements in oncologic outcomes, including overall survival and disease-free survival. Targeted long-term follow-up studies in specific oncologic procedures are required to determine whether ERAS application results in improved oncologic outcomes.

Keywords: Adenocarcinoma/surgery; Analgesia*/mortality; Anesthesia, conduction/adverse effects; Colonic neoplasms/pathology; Colonic neoplasms/surgery; Disease progression; Disease-free survival; Humans; Laparoscopy; Neoplasm recurrence, local/mortality; Neoplasm recurrence, local/prevention and control; Neoplasm staging; Neoplasms/immunology; Neoplasms/mortality; Survival analysis; Treatment outcome.

Publication types

  • Review

MeSH terms

  • Adult
  • Disease-Free Survival
  • Enhanced Recovery After Surgery*
  • Humans
  • Length of Stay
  • Postoperative Complications
  • Surgical Oncology*